These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 24186491)

  • 1. Effector mechanisms of rejection.
    Moreau A; Varey E; Anegon I; Cuturi MC
    Cold Spring Harb Perspect Med; 2013 Nov; 3(11):. PubMed ID: 24186491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology.
    Zecher D; Li Q; Williams AL; Walters JT; Baddoura FK; Chalasani G; Rothstein DM; Shlomchik WD; Demetris AJ; Lakkis FG
    Transpl Immunol; 2012 Mar; 26(2-3):113-8. PubMed ID: 22226941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The innate immune system and transplantation.
    Farrar CA; Kupiec-Weglinski JW; Sacks SH
    Cold Spring Harb Perspect Med; 2013 Oct; 3(10):a015479. PubMed ID: 24086066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the functions of B cells.
    Balin SJ; Platt JL; Cascalho M
    Pediatr Transplant; 2008 Aug; 12(5):510-5. PubMed ID: 18564310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of chemokine involvement in allograft transplantation.
    Melter M; McMahon G; Fang J; Ganz P; Briscoe DM
    Pediatr Transplant; 1999 Feb; 3(1):10-21. PubMed ID: 10359026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector and Regulatory T Cell Trafficking in Corneal Allograft Rejection.
    Amouzegar A; Chauhan SK
    Mediators Inflamm; 2017; 2017():8670280. PubMed ID: 28539707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Necrosis Factor Directs Allograft-Related Innate Responses and Its Neutralization Improves Hepatocyte Engraftment in Rats.
    Jaber FL; Sharma Y; Mui BG; Kapoor S; Gupta S
    Am J Pathol; 2021 Jan; 191(1):79-89. PubMed ID: 33127336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resident memory T cells form during persistent antigen exposure leading to allograft rejection.
    Abou-Daya KI; Tieu R; Zhao D; Rammal R; Sacirbegovic F; Williams AL; Shlomchik WD; Oberbarnscheidt MH; Lakkis FG
    Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33741656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral Response in Liver Allograft Transplantation: A Review of the Role of Anti-Human Leukocyte Antigen (HLA) Antibodies.
    Muro M; Moya-Quiles MR; Mrowiec A
    Curr Protein Pept Sci; 2016; 17(8):776-784. PubMed ID: 26916161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response and histology of humoral rejection in kidney transplantation.
    González-Molina M; Ruiz-Esteban P; Caballero A; Burgos D; Cabello M; Leon M; Fuentes L; Hernandez D
    Nefrologia; 2016; 36(4):354-67. PubMed ID: 27267916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?
    Ravindranath MH; El Hilali F; Filippone EJ
    Front Immunol; 2021; 12():667834. PubMed ID: 34880853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking innate immunity and chronic antibody-mediated allograft rejection.
    Gill RG; Lin CM
    Curr Opin Organ Transplant; 2019 Dec; 24(6):694-698. PubMed ID: 31599762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles in allograft rejection and tolerance.
    Benichou G; Wang M; Ahrens K; Madsen JC
    Cell Immunol; 2020 Mar; 349():104063. PubMed ID: 32087929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ Control of an Effector/Target Combination for Skin Allograft Rejection: Macrophage/Skin Components in Normal Mice or T Cell/Endothelial Cells in IFN-γ-Deficient Mice.
    Yoshida R; Maeda S; Tashiro-Yamaji J; Yasuda E; Shibayama Y; Hirose Y; Kubota T
    J Interferon Cytokine Res; 2020 Apr; 40(4):207-217. PubMed ID: 32069165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of intra-graft B cells during renal allograft rejection.
    Zarkhin V; Kambham N; Li L; Kwok S; Hsieh SC; Salvatierra O; Sarwal MM
    Kidney Int; 2008 Sep; 74(5):664-73. PubMed ID: 18547992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell mediated rejection.
    Wood KJ; Zaitsu M; Goto R
    Methods Mol Biol; 2013; 1034():71-83. PubMed ID: 23775731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response.
    Chalasani G; Li Q; Konieczny BT; Smith-Diggs L; Wrobel B; Dai Z; Perkins DL; Baddoura FK; Lakkis FG
    J Immunol; 2004 Jun; 172(12):7813-20. PubMed ID: 15187165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.
    Alelign T; Ahmed MM; Bobosha K; Tadesse Y; Howe R; Petros B
    J Immunol Res; 2018; 2018():5986740. PubMed ID: 29693023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.